The G1 checkpoint is defective in most cancer cells, commonly due to mutations/alterations of key regulators of the G1 checkpoint (p53, Cyclin D, etc.)(80), whereas activation of the G2 checkpoint is rarely impaired in cancer cells, as this checkpoint operates primarily via a p53-independent mechanism (Fig. 3) (86). This evidence concerns the gene TP53 and cancer.